Global THR- ? Agonists Market Growth (Status and Outlook) 2026-2032

May 2026 | 79 pages | ID: GB873EAA54F5EN
LP Information

Abstracts

The global THR- ? Agonists market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

THR-? (thyroid hormone receptor-beta) agonists are a class of compounds that activate the thyroid hormone receptor-beta, a nuclear receptor involved in regulating gene expression. These agonists bind to the THR-? receptor and stimulate its activity, leading to various physiological effects.

United States market for THR- ? Agonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for THR- ? Agonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for THR- ? Agonists is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key THR- ? Agonists players cover Madrigal Pharmaceuticals, Terns Pharmaceuticals, Ascletis, Haisco Pharmaceutical Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “THR- ? Agonists Industry Forecast” looks at past sales and reviews total world THR- ? Agonists sales in 2025, providing a comprehensive analysis by region and market sector of projected THR- ? Agonists sales for 2026 through 2032. With THR- ? Agonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world THR- ? Agonists industry.

This Insight Report provides a comprehensive analysis of the global THR- ? Agonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on THR- ? Agonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global THR- ? Agonists market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for THR- ? Agonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global THR- ? Agonists.

This report presents a comprehensive overview, market shares, and growth opportunities of THR- ? Agonists market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Specification Below 10mg
• Specification 10-50mg
• Specification Above 50mg

Segmentation by Application:

• Metabolic Diseases
• Cardiovascular Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Madrigal Pharmaceuticals
• Terns Pharmaceuticals
• Ascletis
• Haisco Pharmaceutical Group

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global THR- ? Agonists Market Size (2021-2032)
  2.1.2 THR- ? Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for THR- ? Agonists by Country/Region (2021, 2025 & 2032)
2.2 THR- ? Agonists Segment by Type
  2.2.1 Specification Below 10mg
  2.2.2 Specification 10-50mg
  2.2.3 Specification Above 50mg
  2.2.4 THR- ? Agonists Market Size by Type
    2.2.4.1 THR- ? Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global THR- ? Agonists Market Size Market Share by Type (2021-2026)
2.3 THR- ? Agonists Segment by Application
  2.3.1 Metabolic Diseases
  2.3.2 Cardiovascular Disease
  2.3.3 Others
  2.3.4 THR- ? Agonists Market Size by Application
    2.3.4.1 THR- ? Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global THR- ? Agonists Market Size Market Share by Application (2021-2026)

3 THR- ? AGONISTS MARKET SIZE BY PLAYER

3.1 THR- ? Agonists Market Size Market Share by Player
  3.1.1 Global THR- ? Agonists Revenue by Player (2021-2026)
  3.1.2 Global THR- ? Agonists Revenue Market Share by Player (2021-2026)
3.2 Global THR- ? Agonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 THR- ? AGONISTS BY REGION

4.1 THR- ? Agonists Market Size by Region (2021-2026)
4.2 Global THR- ? Agonists Annual Revenue by Country/Region (2021-2026)
4.3 Americas THR- ? Agonists Market Size Growth (2021-2026)
4.4 APAC THR- ? Agonists Market Size Growth (2021-2026)
4.5 Europe THR- ? Agonists Market Size Growth (2021-2026)
4.6 Middle East & Africa THR- ? Agonists Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas THR- ? Agonists Market Size by Country (2021-2026)
5.2 Americas THR- ? Agonists Market Size by Type (2021-2026)
5.3 Americas THR- ? Agonists Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC THR- ? Agonists Market Size by Region (2021-2026)
6.2 APAC THR- ? Agonists Market Size by Type (2021-2026)
6.3 APAC THR- ? Agonists Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe THR- ? Agonists Market Size by Country (2021-2026)
7.2 Europe THR- ? Agonists Market Size by Type (2021-2026)
7.3 Europe THR- ? Agonists Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa THR- ? Agonists by Region (2021-2026)
8.2 Middle East & Africa THR- ? Agonists Market Size by Type (2021-2026)
8.3 Middle East & Africa THR- ? Agonists Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL THR- ? AGONISTS MARKET FORECAST

10.1 Global THR- ? Agonists Forecast by Region (2027-2032)
  10.1.1 Global THR- ? Agonists Forecast by Region (2027-2032)
  10.1.2 Americas THR- ? Agonists Forecast
  10.1.3 APAC THR- ? Agonists Forecast
  10.1.4 Europe THR- ? Agonists Forecast
  10.1.5 Middle East & Africa THR- ? Agonists Forecast
10.2 Americas THR- ? Agonists Forecast by Country (2027-2032)
  10.2.1 United States Market THR- ? Agonists Forecast
  10.2.2 Canada Market THR- ? Agonists Forecast
  10.2.3 Mexico Market THR- ? Agonists Forecast
  10.2.4 Brazil Market THR- ? Agonists Forecast
10.3 APAC THR- ? Agonists Forecast by Region (2027-2032)
  10.3.1 China THR- ? Agonists Market Forecast
  10.3.2 Japan Market THR- ? Agonists Forecast
  10.3.3 Korea Market THR- ? Agonists Forecast
  10.3.4 Southeast Asia Market THR- ? Agonists Forecast
  10.3.5 India Market THR- ? Agonists Forecast
  10.3.6 Australia Market THR- ? Agonists Forecast
10.4 Europe THR- ? Agonists Forecast by Country (2027-2032)
  10.4.1 Germany Market THR- ? Agonists Forecast
  10.4.2 France Market THR- ? Agonists Forecast
  10.4.3 UK Market THR- ? Agonists Forecast
  10.4.4 Italy Market THR- ? Agonists Forecast
  10.4.5 Russia Market THR- ? Agonists Forecast
10.5 Middle East & Africa THR- ? Agonists Forecast by Region (2027-2032)
  10.5.1 Egypt Market THR- ? Agonists Forecast
  10.5.2 South Africa Market THR- ? Agonists Forecast
  10.5.3 Israel Market THR- ? Agonists Forecast
  10.5.4 Turkey Market THR- ? Agonists Forecast
10.6 Global THR- ? Agonists Forecast by Type (2027-2032)
10.7 Global THR- ? Agonists Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market THR- ? Agonists Forecast

11 KEY PLAYERS ANALYSIS

11.1 Madrigal Pharmaceuticals
  11.1.1 Madrigal Pharmaceuticals Company Information
  11.1.2 Madrigal Pharmaceuticals THR- ? Agonists Product Offered
  11.1.3 Madrigal Pharmaceuticals THR- ? Agonists Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Madrigal Pharmaceuticals Main Business Overview
  11.1.5 Madrigal Pharmaceuticals Latest Developments
11.2 Terns Pharmaceuticals
  11.2.1 Terns Pharmaceuticals Company Information
  11.2.2 Terns Pharmaceuticals THR- ? Agonists Product Offered
  11.2.3 Terns Pharmaceuticals THR- ? Agonists Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Terns Pharmaceuticals Main Business Overview
  11.2.5 Terns Pharmaceuticals Latest Developments
11.3 Ascletis
  11.3.1 Ascletis Company Information
  11.3.2 Ascletis THR- ? Agonists Product Offered
  11.3.3 Ascletis THR- ? Agonists Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Ascletis Main Business Overview
  11.3.5 Ascletis Latest Developments
11.4 Haisco Pharmaceutical Group
  11.4.1 Haisco Pharmaceutical Group Company Information
  11.4.2 Haisco Pharmaceutical Group THR- ? Agonists Product Offered
  11.4.3 Haisco Pharmaceutical Group THR- ? Agonists Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Haisco Pharmaceutical Group Main Business Overview
  11.4.5 Haisco Pharmaceutical Group Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. THR- ? Agonists Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. THR- ? Agonists Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Specification Below 10mg
Table 4. Major Players of Specification 10-50mg
Table 5. Major Players of Specification Above 50mg
Table 6. THR- ? Agonists Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global THR- ? Agonists Market Size by Type (2021-2026) & ($ millions)
Table 8. Global THR- ? Agonists Market Size Market Share by Type (2021-2026)
Table 9. THR- ? Agonists Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global THR- ? Agonists Market Size by Application (2021-2026) & ($ millions)
Table 11. Global THR- ? Agonists Market Size Market Share by Application (2021-2026)
Table 12. Global THR- ? Agonists Revenue by Player (2021-2026) & ($ millions)
Table 13. Global THR- ? Agonists Revenue Market Share by Player (2021-2026)
Table 14. THR- ? Agonists Key Players Head office and Products Offered
Table 15. THR- ? Agonists Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global THR- ? Agonists Market Size by Region (2021-2026) & ($ millions)
Table 19. Global THR- ? Agonists Market Size Market Share by Region (2021-2026)
Table 20. Global THR- ? Agonists Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global THR- ? Agonists Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas THR- ? Agonists Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas THR- ? Agonists Market Size Market Share by Country (2021-2026)
Table 24. Americas THR- ? Agonists Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas THR- ? Agonists Market Size Market Share by Type (2021-2026)
Table 26. Americas THR- ? Agonists Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas THR- ? Agonists Market Size Market Share by Application (2021-2026)
Table 28. APAC THR- ? Agonists Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC THR- ? Agonists Market Size Market Share by Region (2021-2026)
Table 30. APAC THR- ? Agonists Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC THR- ? Agonists Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe THR- ? Agonists Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe THR- ? Agonists Market Size Market Share by Country (2021-2026)
Table 34. Europe THR- ? Agonists Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe THR- ? Agonists Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa THR- ? Agonists Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa THR- ? Agonists Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa THR- ? Agonists Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of THR- ? Agonists
Table 40. Key Market Challenges & Risks of THR- ? Agonists
Table 41. Key Industry Trends of THR- ? Agonists
Table 42. Global THR- ? Agonists Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global THR- ? Agonists Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global THR- ? Agonists Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global THR- ? Agonists Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Madrigal Pharmaceuticals Details, Company Type, THR- ? Agonists Area Served and Its Competitors
Table 47. Madrigal Pharmaceuticals THR- ? Agonists Product Offered
Table 48. Madrigal Pharmaceuticals THR- ? Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Madrigal Pharmaceuticals Main Business
Table 50. Madrigal Pharmaceuticals Latest Developments
Table 51. Terns Pharmaceuticals Details, Company Type, THR- ? Agonists Area Served and Its Competitors
Table 52. Terns Pharmaceuticals THR- ? Agonists Product Offered
Table 53. Terns Pharmaceuticals THR- ? Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Terns Pharmaceuticals Main Business
Table 55. Terns Pharmaceuticals Latest Developments
Table 56. Ascletis Details, Company Type, THR- ? Agonists Area Served and Its Competitors
Table 57. Ascletis THR- ? Agonists Product Offered
Table 58. Ascletis THR- ? Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Ascletis Main Business
Table 60. Ascletis Latest Developments
Table 61. Haisco Pharmaceutical Group Details, Company Type, THR- ? Agonists Area Served and Its Competitors
Table 62. Haisco Pharmaceutical Group THR- ? Agonists Product Offered
Table 63. Haisco Pharmaceutical Group THR- ? Agonists Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Haisco Pharmaceutical Group Main Business
Table 65. Haisco Pharmaceutical Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. THR- ? Agonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global THR- ? Agonists Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. THR- ? Agonists Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. THR- ? Agonists Sales Market Share by Country/Region (2025)
Figure 8. THR- ? Agonists Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global THR- ? Agonists Market Size Market Share by Type in 2025
Figure 10. THR- ? Agonists in Metabolic Diseases
Figure 11. Global THR- ? Agonists Market: Metabolic Diseases (2021-2026) & ($ millions)
Figure 12. THR- ? Agonists in Cardiovascular Disease
Figure 13. Global THR- ? Agonists Market: Cardiovascular Disease (2021-2026) & ($ millions)
Figure 14. THR- ? Agonists in Others
Figure 15. Global THR- ? Agonists Market: Others (2021-2026) & ($ millions)
Figure 16. Global THR- ? Agonists Market Size Market Share by Application in 2025
Figure 17. Global THR- ? Agonists Revenue Market Share by Player in 2025
Figure 18. Global THR- ? Agonists Market Size Market Share by Region (2021-2026)
Figure 19. Americas THR- ? Agonists Market Size 2021-2026 ($ millions)
Figure 20. APAC THR- ? Agonists Market Size 2021-2026 ($ millions)
Figure 21. Europe THR- ? Agonists Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa THR- ? Agonists Market Size 2021-2026 ($ millions)
Figure 23. Americas THR- ? Agonists Value Market Share by Country in 2025
Figure 24. United States THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC THR- ? Agonists Market Size Market Share by Region in 2025
Figure 29. APAC THR- ? Agonists Market Size Market Share by Type (2021-2026)
Figure 30. APAC THR- ? Agonists Market Size Market Share by Application (2021-2026)
Figure 31. China THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 35. India THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe THR- ? Agonists Market Size Market Share by Country in 2025
Figure 38. Europe THR- ? Agonists Market Size Market Share by Type (2021-2026)
Figure 39. Europe THR- ? Agonists Market Size Market Share by Application (2021-2026)
Figure 40. Germany THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 41. France THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 42. UK THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa THR- ? Agonists Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa THR- ? Agonists Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa THR- ? Agonists Market Size Market Share by Application (2021-2026)
Figure 48. Egypt THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries THR- ? Agonists Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 54. APAC THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 55. Europe THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 57. United States THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 58. Canada THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 59. Mexico THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 60. Brazil THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 61. China THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 62. Japan THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 63. Korea THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 65. India THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 66. Australia THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 67. Germany THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 68. France THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 69. UK THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 70. Italy THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 71. Russia THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 72. Egypt THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 73. South Africa THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 74. Israel THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 75. Turkey THR- ? Agonists Market Size 2027-2032 ($ millions)
Figure 76. Global THR- ? Agonists Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global THR- ? Agonists Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries THR- ? Agonists Market Size 2027-2032 ($ millions)